Skip to content

Clinical trials

Observational Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20065
20078
20089
20098
20103
20122
20132
20143
20154
20165
20174
20182
20198
20209
20213
20227
20239
20249
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting21
Unknown status17
Terminated11
Not yet recruiting8
Active, not recruiting5
Withdrawn4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Brest8
Assistance Publique - Hôpitaux de Paris5
Assiut University5
University Hospital, Bordeaux5
City of Hope Medical Center4
Vanderbilt-Ingram Cancer Center4
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
OHSU Knight Cancer Institute3
Fondazione IRCCS Policlinico San Matteo di Pavia2
Icahn School of Medicine at Mount Sinai2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders117
Primary Myelofibrosis34
Myelodysplastic Syndromes32
Leukemia, Myeloid, Acute28
Multiple Myeloma28
Leukemia27
Lymphoma25
Precursor Cell Lymphoblastic Leukemia-Lymphoma25
Lymphoma, Non-Hodgkin24
Hodgkin Disease23

Trials

Showing 51 to 75 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.